BioCentury This Week - podcast cover

BioCentury This Week

BioCentury•www.biocentury.com

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Last refreshed: June 30th, 2025 at 1:15 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Ep. 101 - Of Biotech Bears, Pazdur & PDUFA

Weathering the bear market. Oncology chief’s change in thinking on PD-1 therapies. Plus BioCentury’s 2021 innovative start-ups. This week’s podcast is sponsored by ICON . Reach us by sending a text

Feb 08, 2022•29 min•Season 3Ep. 101

Ep. 100 - Capital markets check in; plus Belgium’s prodigal son returns

This week’s podcast is sponsored by ICON . Reach us by sending a text

Feb 01, 2022•27 min•Season 3Ep. 100

Ep. 99 - Introducing The BioCentury Show, Plus Califf, COVID and GSK

BioCentury’s new in-depth conversational series launches with Scott Gottlieb as debut guest. This week’s podcast is sponsored by ICON . Reach us by sending a text

Jan 25, 2022•26 min•Season 3Ep. 99

Ep. 98 - Bargain Hunting in a Rocky Market, plus Advantage, CMS

Part two of BioCentury’s 2022 Financial Markets Preview, access to Alzheimer’s mAbs, and translational highlights from the Distillery. This week’s podcast is sponsored by ICON . Reach us by sending a text

Jan 19, 2022•24 min•Season 3Ep. 98

Ep. 97 - Buysiders' Picks, plus JPM22 roundup

Reach us by sending a text

Jan 11, 2022•28 min•Season 3Ep. 97

Ep. 96 - Aduhelm, Pazdur, Pharma Digital & '21 Wrap

Reach us by sending a text

Dec 21, 2021•23 min•Season 2Ep. 96

Ep. 95 - ASH's New Targets, Avistone & Washington Update

Reach us by sending a text

Dec 14, 2021•20 min•Season 2Ep. 95

Ep. 94 - Woodcock's To-Do List, Maraganore's Takeaways & the Distillery

Reach us by sending a text

Dec 07, 2021•23 min•Season 2Ep. 94

Ep. 93 - Omicron's Open Questions, Plus the Business Case for Ultra-rare Diseases

Reach us by sending a text

Nov 30, 2021•20 min•Season 2Ep. 93

Ep. 92 - Biogen’s R&D decision, previewing TIGIT & China Summit highlights

Reach us by sending a text

Nov 22, 2021•23 min•Season 2Ep. 92

Ep. 91 - China Summit Highlights: Day 2

Reach us by sending a text

Nov 18, 2021•39 min•Season 2Ep. 91

Ep. 90 - China Summit Highlights: Day 1

Reach us by sending a text

Nov 17, 2021•36 min•Season 2Ep. 90

Ep. 89 - Califf's Passions, RWE in China & LSP Rising

Reach us by sending a text

Nov 16, 2021•33 min•Season 2Ep. 89

Ep. 88 - China Summit Preview: The Bridge to Innovation

Reach us by sending a text

Nov 10, 2021•28 min•Season 2Ep. 88

Ep. 87 - Digesting Drug Pricing, Plus Access in ALS

Reach us by sending a text

Nov 09, 2021•33 min•Season 2Ep. 87

Ep. 86 - Woodcock's Legacy, Plus Frazier, Bain & the Distillery

Reach us by sending a text

Nov 02, 2021•27 min•Season 2Ep. 86

Ep. 85 - What's Next for CRISPR & Gene Therapy, Plus China Summit Preview

Reach us by sending a text

Oct 26, 2021•23 min•Season 2Ep. 85

Ep. 84 - Why Gene Therapy's Bad Year Is a Speed Bump, Not a Dead End

Reach us by sending a text

Oct 22, 2021•23 min•Season 2Ep. 84

Ep. 83 - Assessing Biogen’s ALS Miss, Plus Califf on Deck

Reach us by sending a text

Oct 18, 2021•23 min•Season 2Ep. 83

Ep. 82 - 4Q Markets Preview, Plus the Future of NIH

Reach us by sending a text

Oct 12, 2021•31 min•Season 2Ep. 82

Ep. 81 - Merck & the State of M&A, Plus Novartis CEO's Call to Action

Reach us by sending a text

Oct 05, 2021•22 min•Season 2Ep. 81

Ep. 80 - Hong Kong Rising, Plus Varmus' POV & Biden's FDA Choice

Reach us by sending a text

Sep 28, 2021•27 min•Season 2Ep. 80

Ep. 79 - ESMO, Jeito & the Latest from Washington

Reach us by sending a text

Sep 21, 2021•23 min•Season 2Ep. 79

Ep. 78 - Remembering Fred Frank, Lisa Raines, Plus CRISPR, Washington Updates

Reach us by sending a text

Sep 14, 2021•27 min•Season 2Ep. 78

Ep. 77 - Back to School Spotlight & Pressures on FDA

Reach us by sending a text

Sep 04, 2021•22 min•Season 2Ep. 77

Ep 76 Pt. 4 - Modifying Access for Accelerated Approvals

Reach us by sending a text

Sep 01, 2021•14 min•Season 2Ep. 76

Ep 76 Pt. 3 - Delivering the Evidence for Accelerated Approval

Reach us by sending a text

Sep 01, 2021•15 min•Season 2Ep. 76

Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval

Reach us by sending a text

Aug 30, 2021•15 min•Season 2Ep. 76

Ep 76 Pt. 1 - Accelerated Approval's Big Picture

Reach us by sending a text

Aug 30, 2021•22 min•Season 2Ep. 76

Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium

Reach us by sending a text

Aug 24, 2021•23 min•Season 2Ep. 75

← Prev Next →

Hosted on Buzzsprout

For the best experience, listen in Metacast app for iOS or Android